{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:27:18Z","timestamp":1760369238835},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30900673"],"award-info":[{"award-number":["30900673"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wu Jieping Medical Foundation of China","award":["320.6977.1134"],"award-info":[{"award-number":["320.6977.1134"]}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["SJ08-ZT10"],"award-info":[{"award-number":["SJ08-ZT10"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation of Health Department of Shaanxi Province","award":["2012D13"],"award-info":[{"award-number":["2012D13"]}]},{"DOI":"10.13039\/100005366","name":"AFAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.yjmcc.2015.07.027","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T12:59:11Z","timestamp":1438433951000},"page":"158-167","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The mammalian target of rapamycin modulates the immunoproteasome system in the heart"],"prefix":"10.1016","volume":"86","author":[{"given":"Hong-Mei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.07.027_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","article-title":"mTOR inhibitors in cancer therapy","volume":"319","author":"Zaytseva","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0020","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4049\/jimmunol.0903182","article-title":"Prevention of experimental colitis by a selective inhibitor of the immunoproteasome","volume":"185","author":"Basler","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0030","doi-asserted-by":"crossref","first-page":"H645","DOI":"10.1152\/ajpheart.00196.2007","article-title":"Proteasome inhibition promotes regression of left ventricular hypertrophy","volume":"294","author":"Stansfield","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0035","doi-asserted-by":"crossref","DOI":"10.4161\/cc.10.12.15858","article-title":"mTOR signaling in protein homeostasis: less is more?","volume":"10","author":"Conn","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0040","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1091\/mbc.E08-12-1250","article-title":"An Atg1\/Atg13 complex with multiple roles in TOR-mediated autophagy regulation","volume":"20","author":"Chang","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","article-title":"The ubiquitin-proteasome proteolytic pathway","volume":"79","author":"Ciechanover","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0050","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1248\/bpb.32.988","article-title":"Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation","volume":"32","author":"Jin","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0055","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0060","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/eji.1830271106","article-title":"Rapamycin inhibits proteasome activator expression and proteasome activity","volume":"27","author":"Wang","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbrc.2009.06.080","article-title":"Repression of protein translation and mTOR signaling by proteasome inhibitor in colon cancer cells","volume":"386","author":"Wu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4161\/cc.7.3.5267","article-title":"mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase","volume":"7","author":"Ghosh","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","article-title":"The ubiquitin-proteasome system: focus on the heart","volume":"70","author":"Zolk","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tcm.2012.04.005","article-title":"Cardiovascular disease and mTOR signaling","volume":"21","author":"Chong","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0090","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/sj.cdd.4401692","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","volume":"12","author":"Ciechanover","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.yjmcc.2011.10.023","article-title":"Back to your heart: ubiquitin proteasome system-regulated signal transduction","volume":"52","author":"Portbury","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yjmcc.2006.07.015","article-title":"Into the heart: the emerging role of the ubiquitin-proteasome system","volume":"41","author":"Willis","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.187.1.97","article-title":"Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits","volume":"187","author":"Griffin","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a124327","article-title":"Interferon-gamma induces different subunit organizations and functional diversity of proteasomes","volume":"115","author":"Aki","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.expneurol.2005.08.027","article-title":"Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines","volume":"196","author":"Puttaparthi","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0120","doi-asserted-by":"crossref","first-page":"35196","DOI":"10.1074\/jbc.274.49.35196","article-title":"Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1","volume":"274","author":"Foss","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood.V98.4.1108","article-title":"Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface","volume":"98","author":"Hallermalm","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0130","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1096\/fj.08-105940","article-title":"Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency","volume":"22","author":"Cai","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/ATVBAHA.109.189407","article-title":"Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome","volume":"29","author":"Yang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/BJ20100878","article-title":"The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes","volume":"432","author":"Pickering","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","article-title":"Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress","volume":"142","author":"Seifert","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0150","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2353\/ajpath.2006.050865","article-title":"Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes","volume":"168","author":"Szalay","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0155","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ajpath.2012.08.040","article-title":"Interferon-gamma causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis","volume":"181","author":"Cosper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2009.090033","article-title":"Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis","volume":"175","author":"Jakel","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0267659108100708","article-title":"Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis","volume":"23","author":"Anderson","year":"2008","journal-title":"Perfusion"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2249.2012.04578.x","article-title":"Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice","volume":"168","author":"Nagayama","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00788278","article-title":"Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light","volume":"89","author":"Whittaker","year":"1994","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-60761-756-3_12","article-title":"Determination of proteasomal activities","volume":"648","author":"Lima","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.med.50.1.57","article-title":"The ubiquitin-proteasome pathway and pathogenesis of human diseases","volume":"50","author":"Schwartz","year":"1999","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.03.005","article-title":"How can I halt thee? The puzzles involved in autophagic inhibition","volume":"82","author":"Vinod","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1006814306401","article-title":"Regulation of proteasome structure and function","volume":"24","author":"Rivett","year":"1997","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0300-9084(01)01249-4","article-title":"Regulation of proteasome complexes by gamma-interferon and phosphorylation","volume":"83","author":"Rivett","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jlb.56.5.571","article-title":"Role of proteasomes modified by interferon-gamma in antigen processing","volume":"56","author":"Tanaka","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0220","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1006\/jmcc.2001.1385","article-title":"Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes","volume":"33","author":"Bergmann","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0225","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/353662a0","article-title":"Subunit of the \u201820S\u2019 proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex","volume":"353","author":"Ortiz-Navarrete","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0230","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1006\/cyto.2000.0717","article-title":"Control of LMP7 expression in human endothelial cells by cytokines regulating cellular and humoral immunity","volume":"12","author":"Loukissa","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0235","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.4049\/jimmunol.177.12.8393","article-title":"Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes","volume":"177","author":"Callahan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0240","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.107.097816","article-title":"Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system","volume":"51","author":"Meiners","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0245","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","article-title":"Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy","volume":"114","author":"Depre","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0250","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.110.222364","article-title":"Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy","volume":"107","author":"Drews","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-61779-474-2_27","article-title":"Immunoproteasome-specific inhibitors and their application","volume":"832","author":"Basler","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/07853890310016324","article-title":"The ubiquitin-proteasome pathway","volume":"36","author":"Roos-Mattjus","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0265","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00062.2006","article-title":"The ubiquitin-proteasome system in cardiac physiology and pathology","volume":"291","author":"Powell","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0270","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.biocel.2013.07.019","article-title":"Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle","volume":"45","author":"Joassard","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0275","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/leu.2013.150","article-title":"Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K\/mTOR inhibition in myeloma cells is essential for their effective clinical application","volume":"27","author":"Aronson","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0280","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/leu.2012.118","article-title":"Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt\/mTOR pathway in MCL","volume":"26","author":"Hutter","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0285","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr1533","article-title":"The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells","volume":"8","author":"Shapira","year":"2006","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2010.02.007","article-title":"Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice","volume":"49","author":"Zu","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphys.2013.00042","article-title":"Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle","volume":"4","author":"Voigt","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0300","first-page":"119","article-title":"Rapamycin extends life and health in C57BL\/6 mice","volume":"69","author":"Zhang","year":"2013","journal-title":"J. Gerontol. A: Biol. Med. Sci."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0305","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0310","doi-asserted-by":"crossref","first-page":"535241","DOI":"10.4061\/2011\/535241","article-title":"Cellular Interplay between cardiomyocytes and nonmyocytes in cardiac remodeling","volume":"2011","author":"Takeda","year":"2011","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0315","doi-asserted-by":"crossref","first-page":"H1696","DOI":"10.1152\/ajpheart.00545.2010","article-title":"Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium","volume":"300","author":"Harston","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0320","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0325","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood-2006-06-030833","article-title":"Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0330","doi-asserted-by":"crossref","first-page":"e83908","DOI":"10.1371\/journal.pone.0083908","article-title":"Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0335","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0340","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/000313480407000503","article-title":"Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells","volume":"70","author":"Adkins","year":"2004","journal-title":"Am. Surg."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0345","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.04-2431fje","article-title":"Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty","volume":"19","author":"Nuhrenberg","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0350","doi-asserted-by":"crossref","first-page":"H2459","DOI":"10.1152\/ajpheart.00750.2005","article-title":"Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis","volume":"290","author":"Giordano","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0355","doi-asserted-by":"crossref","first-page":"868753","DOI":"10.1155\/2014\/868753","article-title":"Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-kappaB activation","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0360","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.hjh.0000239304.01496.83","article-title":"Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis","volume":"24","author":"Gao","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0365","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0370","doi-asserted-by":"crossref","first-page":"29109","DOI":"10.1074\/jbc.M802143200","article-title":"Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta","volume":"283","author":"Smeets","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0375","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02938356","article-title":"Role of inflammation in the progression of heart failure","volume":"9","author":"Yndestad","year":"2007","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0380","doi-asserted-by":"crossref","first-page":"e35144","DOI":"10.1371\/journal.pone.0035144","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0385","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00395-014-0428-7","article-title":"Cardiac fibroblasts support cardiac inflammation in heart failure","volume":"109","author":"Lindner","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-7843.2007.00147.x","article-title":"Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?","volume":"102","author":"Balakumar","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0395","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.hfc.2011.08.002","article-title":"From risk factors to structural heart disease: the role of inflammation","volume":"8","author":"Kalogeropoulos","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0400","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2353\/ajpath.2010.090622","article-title":"A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis","volume":"176","author":"Deng","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0405","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1476-5381.2008.00080.x","article-title":"Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor","volume":"156","author":"Zhao","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0410","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1476-5381.2008.00102.x","article-title":"Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels","volume":"156","author":"Chen","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2015.07.027_bb0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815300286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815300286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T09:28:21Z","timestamp":1718011701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282815300286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":83,"alternative-id":["S0022282815300286"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.07.027","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mammalian target of rapamycin modulates the immunoproteasome system in the heart","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}